Title : Irinotecan pathway genotype analysis to predict pharmacokinetics.

Pub. Date : 2003 Aug 15

PMID : 12960109






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The homozygous T allele of the ABCB1 1236C>T polymorphism was associated with significantly increased exposure to irinotecan (P = 0.038) and its active metabolite SN-38 (P = 0.031). Irinotecan ATP binding cassette subfamily B member 1 Homo sapiens
2 The homozygous T allele of the ABCB1 1236C>T polymorphism was associated with significantly increased exposure to irinotecan (P = 0.038) and its active metabolite SN-38 (P = 0.031). Irinotecan ATP binding cassette subfamily B member 1 Homo sapiens
3 CONCLUSIONS: It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Irinotecan ATP binding cassette subfamily B member 1 Homo sapiens